Financhill
Back

Karyopharm Therapeutics Stock Predictions

Karyopharm Therapeutics Stock Forecast

  • Is Karyopharm Therapeutics Stock Undervalued?
    The current Karyopharm Therapeutics [KPTI] share price is $1.28. The Score for KPTI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • KPTI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Karyopharm Therapeutics Stock Go Up Next Year?

Data Unavailable

Karyopharm Therapeutics Stock Rating

Data Unavailable

Karyopharm Therapeutics Stock Price History

Is KPTI stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
karyopharm.com

52-Week Data

52-Week High:
4.11
52-Week Low:
0.62

Prediction Charts

Market Cap:
146.71M
Price in USD:
1.28
Volume:
1.22M
Beta:
0.83

Technical Analysis

SMA50:
1.35
SMA100:
1.10
SMA200:
1.19
52-Wk Change:
-69.28%

Stock Predictions

  • Is Karyopharm Therapeutics stock public?
    Yes, Karyopharm Therapeutics is a publicly traded company.
  • What is the Karyopharm Therapeutics stock quote today?
    The Karyopharm Therapeutics stock price is 1.28 USD today.
  • How to buy Karyopharm Therapeutics stock online?
    You can buy Karyopharm Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-1 1.51 1.59 1.65 1.45
Apr-2 1.55 1.40 1.56 1.38
Apr-3 1.39 1.28 1.39 1.28
Apr-4 1.29 1.33 1.44 1.25
Apr-5 1.31 1.36 1.41 1.28
Apr-8 1.38 1.35 1.39 1.29
Apr-9 1.33 1.34 1.41 1.31
Apr-10 1.31 1.26 1.34 1.25
Apr-11 1.28 1.33 1.34 1.26
Apr-12 1.34 1.22 1.35 1.18
Apr-15 1.22 1.15 1.23 1.14
Apr-16 1.14 1.09 1.20 1.03
Apr-17 1.19 1.38 1.38 1.14
Apr-18 1.42 1.28 1.42 1.22

Karyopharm Therapeutics Earnings

Data Unavailable

Karyopharm Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.02 per share, and an increase next year of $0.20 per share.

* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.